15 May 2014 15 May 2014 Calon to unveil new MiniVAD design at ASAIO June 2014
Calon, the innovative LVAD company, is delighted to announce that it will provide an update on its innovative Ventricular Assist Device, MiniVAD, at the forthcoming American Society for Artificial Internal Organs conference in Washington DC on 19th June. The newly designed passive maglev and pivot bearing design will be unveiled for the first time. Additionally comparative blood damage data that demonstrates significantly lowered potential for blood damage compared to previous VAD designs will also be presented.
In addition on 20th June Calon will present its 'handbook' of in-vitro blood tests conducted in multiple species for the first time. This broad range of blood component tests is a fundamental component of the early design and perfomance validation process that enables rapid feedback on pump pefomance and minimises the use of in-vivo studies.
Graham Foster, CTO commented “It is very rewarding to present an update on our work to this prestigious meeting and to have our efforts to properly assess the impact of rotary blood pumps on whole blood function recognised by the scientific and medical community.”
For more information contact Graham Foster, Chief Technology Officer, on +44 (0)1792 602811
Disclaimer: Calon Cardio’s VAD devices are not available for sale, including in the United States of America
- 9th Dec: What's it like to live with a mechanical heart pump?
- 24th Jun: UK's first heart pump targets 2018 clinical trial
- 11th Oct: Stuart McConchie appointed CEO, Board changes
- 11th Jun: CEO Honoured
- 22nd Nov: Calon wins 2015 Frost & Sullivan Innovation Award
- 28th Jul: Calon completes Series B round with new investors
- 29th Nov: US patent granted
- 29th Nov: Calon to present technical update at 8th EUMS
- 14th Mar: Calon wins TSB Biomedical Catalyst Award
- 15th Nov: Calon to present MiniVAD performance data at 7th EUMS meeting
- 3rd Sep: Calon to present MinVAD update at 20th Congress of the ISRBP, Istanbul
- 18th Mar: Calon Cardio-Technology appoints Simon Cartmell
- 23rd Feb: Calon Cardio-Technology, Series B funding
- 17th Jan: Calon Cardio-Technology relocates to ILS2